The industry has thrown tech at the problem, consolidated, and invested in every which way. But we haven’t fundamentally rethought how care is designed, delivered, or sustained. And until we do, no amount of technology will restore what healthcare has lost: its humanity. Here’s how to do that. The post The Future of Healthcare Isn’t…
Kernesha Weatherly, D.H.A., vice president of imaging services and provider practice, explains impact of widespread implementation
SPRINGFIELD, Ohio — Tyeesha Ferguson fears her 28-year-old son will kill or be killed. “That’s what I’m trying to avoid,” said Ferguson, who still calls Quincy Jackson III her baby. She remembers a boy who dressed himself in three-piece suits, donated his allowance, and graduated high school at 16 with an academic scholarship and plans…
With employee anxiety at an all-time high, reducing fear and stress is increasingly important to organizational performance. While leaders cannot control external events, they can help mitigate their impacts on their organizations and people. The post Treating Uncertainty: How Successful Pharma Leaders Can Protect Employee Wellbeing and the Bottom Line appeared first on MedCity News.
The conversations in Nashville reinforced the idea that while innovation remains essential, vendors must navigate the fine balance between bold ideas and real-world implementation, demonstrating not just promise but tangible outcomes. The post ViVE 2025: The Crossroads of Digital Health Innovation and Realities appeared first on MedCity News.
Health tech companies made several major funding announcements in September. Here is a list of some of the biggest funding rounds. The post 5 Notable Health Tech Funding Announcements in September appeared first on MedCity News.
Carta Healthcare buys UPMC-backed Realize Intelligence, which focuses on data abstraction in oncology
Sustainable quality doesn’t live in binders or dashboards; it lives in the small, repeatable actions that happen every day. The post Making Quality a Daily Habit appeared first on MedCity News.
Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers. The post Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation appeared first on MedCity News.
That is the title of a new paper out in Value in Health with co-authors Jaehong Kim, Jacob Fajnor, Kyi-Sin Than, Elizabeth S. Mearns , Stacey L. Kowal, Thomas Majda and Jakub P. Hlávka PhD. The abstract is below. Objectives To quantify how incorporating patient risk preferences and severity adjustments affect the value of a…